These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 30292443)
1. [Demographic evolution, clinical characteristics and in-hospital outcomes of older adults treated by primary angioplasty for ST-segment elevation myocardial infarction]. Laghlam D; Diefenbronn M; Varenne O; Picard F Ann Cardiol Angeiol (Paris); 2019 Feb; 68(1):6-12. PubMed ID: 30292443 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: Lessons from CRAC, a French prospective multicentre registry. Rangé G; Saint Etienne C; Marcollet P; Chassaing S; Dequenne P; Hakim R; Capsec J; Laure C; Gautier S; Albert F; Godillon L; Stolt P; Motreff P; Grammatico-Guillon L Arch Cardiovasc Dis; 2019 Jan; 112(1):3-11. PubMed ID: 30655225 [TBL] [Abstract][Full Text] [Related]
3. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684 [TBL] [Abstract][Full Text] [Related]
4. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820 [TBL] [Abstract][Full Text] [Related]
5. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ; Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry. Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E; Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029 [TBL] [Abstract][Full Text] [Related]
8. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. Cerrato E; Forno D; Ferro S; Chinaglia A J Cardiovasc Med (Hagerstown); 2017 Aug; 18(8):567-571. PubMed ID: 28504982 [TBL] [Abstract][Full Text] [Related]
9. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry. Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P; Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465 [TBL] [Abstract][Full Text] [Related]
10. French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data. Belle L; Cayla G; Cottin Y; Coste P; Khalife K; Labèque JN; Farah B; Perret T; Goldstein P; Gueugniaud PY; Braun F; Gauthier J; Gilard M; Le Heuzey JY; Naccache N; Drouet E; Bataille V; Ferrières J; Puymirat E; Schiele F; Simon T; Danchin N; Arch Cardiovasc Dis; 2017; 110(6-7):366-378. PubMed ID: 28647465 [TBL] [Abstract][Full Text] [Related]
11. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ; Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339 [TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty. Romano M; Buffoli F; Tomasi L; Corrado L; Ferrari MR; Zanini R Catheter Cardiovasc Interv; 2008 May; 71(6):759-63. PubMed ID: 18412066 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B; Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990 [TBL] [Abstract][Full Text] [Related]
14. Age-Related Differences in Reperfusion Therapy and Outcomes for ST-Segment Elevation Myocardial Infarction. Turk J; Fourny M; Yayehd K; Picard N; Ageron FX; Boussat B; Belle L; Vanzetto G; Puymirat E; Labarère J; Debaty G J Am Geriatr Soc; 2018 Jul; 66(7):1325-1331. PubMed ID: 29684242 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
17. Effect of improved door-to-balloon time on clinical outcomes in patients with ST segment elevation myocardial infarction. Lee WC; Fang HY; Chen HC; Hsueh SK; Chen CJ; Yang CH; Yip HK; Hang CL; Wu CJ; Fang CY Int J Cardiol; 2017 Aug; 240():66-71. PubMed ID: 28390745 [TBL] [Abstract][Full Text] [Related]
18. Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians. Petroni T; Zaman A; Georges JL; Hammoudi N; Berman E; Segev A; Juliard JM; Barthelemy O; Silvain J; Choussat R; Le Feuvre C; Helft G Heart; 2016 Oct; 102(20):1648-54. PubMed ID: 27411839 [TBL] [Abstract][Full Text] [Related]
19. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. Saltzman AJ; Stone GW; Claessen BE; Narula A; Leon-Reyes S; Weisz G; Brodie B; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Metzger DC; Lansky AJ; Nikolsky E; Dangas GD; Mehran R JACC Cardiovasc Interv; 2011 Sep; 4(9):1011-9. PubMed ID: 21939942 [TBL] [Abstract][Full Text] [Related]
20. Delayed versus immediate stenting during STEMI: Towards a "tailored" strategy for primary PCI? Harbaoui B; Motreff P; Lantelme P Arch Cardiovasc Dis; 2016; 109(6-7):373-5. PubMed ID: 27173055 [No Abstract] [Full Text] [Related] [Next] [New Search]